Increased activity of the autonomic nervous system and increased sensitivity to angiotensin II infusion after therapy with recombinant human erythropoietin.
Jandeleit
K
K
Heintz
B
B
Gross-Heitfeld
E
E
Kindler
J
J
Sieberth
H G
HG
Kirsten
R
R
Nelson
K
K
D000804:Angiotensin II / Q000008:administration & dosage; D001341:Autonomic Nervous System / Q000187:drug effects* / Q000503:physiopathology; D004351:Drug Resistance; D004921:Erythropoietin / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D009638:Norepinephrine / Q000097:blood; D006435:Renal Dialysis
D004921:Erythropoietin; D000804:Angiotensin II; D009638:Norepinephrine